Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug

Francesco Passamonti; Mario Cazzola

Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug

Francesco Passamonti, Mario Cazzola

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1284-1286
Number of pages	3
Journal	Haematologica
Volume	89
Issue number	11
Publication status	Published - Nov 2004

ASJC Scopus subject areas

Hematology

Access to Document

Cite this

@article{b3e21b75db834c77993805d2327e3ec1,

title = "Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug",

author = "Francesco Passamonti and Mario Cazzola",

year = "2004",

month = nov,

language = "English",

volume = "89",

pages = "1284--1286",

journal = "Haematologica",

issn = "0390-6078",

publisher = "NLM (Medline)",

number = "11",

}

TY - JOUR

T1 - Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug

AU - Passamonti, Francesco

AU - Cazzola, Mario

PY - 2004/11

Y1 - 2004/11

UR - http://www.scopus.com/inward/record.url?scp=9144234110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144234110&partnerID=8YFLogxK

M3 - Article

C2 - 15531447

AN - SCOPUS:9144234110

VL - 89

SP - 1284

EP - 1286

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 11

ER -